Vaccine Lab / Alfa Chemistry
Multifunctional DSPE-PEG for Empowering Vaccine Development
Contact Us

Our customer services representatives are available 24 hours a day, from Monday to Sunday.

CONTACT US

Multifunctional DSPE-PEG for Empowering Vaccine Development

What Is DSPE-PEG?

DSPE-PEG, short for 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[amino(polyethylene glycol)], is a synthetic phospholipid that is widely utilized in various pharmaceutical and biomedical applications due to its unique properties.

Structure and Properties of DSPE-PEG

  • Structure of DSPE-PEG

DSPE-PEG a synthetic amphiphilic molecule consisting of a phospholid(DSPE) and a polyethylene glycol (PEG) chain. The DSPE component provides the hydrophobic "tail," while the PEG portion serves as biocompatible hydrophilic "head." This unique structure gives DSPE-PEG excellent biocompatibility and amphipathic properties, making it suitable for forming stable liposome nanoparticles in aqueous environments.

  • Properties of DSPE-PEG

The PEGylation of DSPE imparts several advantageous properties to the resulting block copolymers. Notably, PEGylation enhances the solubility of DSPE-PEG aqueous media, reduces nonspecific protein binding, prolongs circulation time in the bloodstream, and improves biocompatibility. Additionally, the terminal groups of DSPE-PEG can be readily activated and modified with ligands, enabling targeted drug delivery applications.

  • Key Effects of Molecular Weight

Chemical structure of DSPE-PEG.Chemical structure of DSPE-PEG. [1]

The molecular weight of DSPE-PEG, specifically the length of the polyethylene glycol (PEG) chain attached to the DSPE moiety, can have significant effects on its properties and functionalities. Some key effects of DSPE-PEG molecular weight include:

  • Solubility
  • Stability
  • Circulation Half-Life
  • Biocompatibility
  • Drug Delivery
  • Cellular Uptake

Quick Selection List for DSPE-PEG

CatalogProductCatalogProduct
ACMA00024671DSPE-PEG10000-CREKAACMA00024711DSPE-PEG3400-CREKA
ACMA00024672DSPE-PEG10000-GE11ACMA00024712DSPE-PEG3400-NBD
ACMA00024673DSPE-PEG10000-MannoseACMA00024713DSPE-PEG3400-NGR
ACMA00024674DSPE-PEG10000-RGDACMA00024714DSPE-PEG3400-T7(HAIYPRH)
ACMA00024675DSPE-PEG10000-SP94ACMA00024716DSPE-PEG3400-YIGSR
ACMA00024676DSPE-PEG10000-TATACM1938081403-1DSPE-PEG5000-Azide
ACMA00024677DSPE-PEG1000-CREKAACMA00024717DSPE-PEG5000-CREKA
ACMA00024678DSPE-PEG1000-FITCACMA00024718DSPE-PEG5000-FITC
ACMA00024679DSPE-PEG1000-FolateACMA00024719DSPE-PEG5000-Folate
ACMA00024680DSPE-PEG1000-GE11ACMA00024720DSPE-PEG5000-GE11
ACMA00024681DSPE-PEG1000-MALACMA00024721DSPE-PEG5000-MAL
ACMA00024682DSPE-PEG1000-NHSACMA00024722DSPE-PEG5000-Mannose
ACMA00024683DSPE-PEG1000-OHACMA00024723DSPE-PEG5000-NBD
ACMA00024684DSPE-PEG1000-OPSSACMA00024724DSPE-PEG5000-NGR
ACMA00024685DSPE-PEG1000-OTCACMA00024725DSPE-PEG5000-NHS
ACMA00024686DSPE-PEG1000-PTPACMA00024726DSPE-PEG5000-OH
ACMA00024687DSPE-PEG1000-RGDACMA00024727DSPE-PEG5000-OPSS
ACMA00024688DSPE-PEG1000-SHACMA00024728DSPE-PEG5000-OTC
ACMA00024689DSPE-PEG1000-SilaneACMA00024729DSPE-PEG5000-PTP
ACMA00024690DSPE-PEG1000-TATACMA00024730DSPE-PEG5000-RGD
ACM1236288257DSPE-PEG2000-Folic acidACMA00024731DSPE-PEG5000-SH
ACM1938081403DSPE-PEG2000-AzideACMA00024732DSPE-PEG5000-Silane
ACM474922220DSPE-PEG2000-MALACMA00024733DSPE-PEG5000-SP94
ACMA00024691DSPE-PEG2000-CREKAACMA00024734DSPE-PEG5000-T7(HAIYPRH)
ACMA00024692DSPE-PEG2000-FITCACMA00024735DSPE-PEG5000-TAT
ACMA00024693DSPE-PEG2000-Folate
ACMA00024694DSPE-PEG2000-Mannose
ACMA00024695DSPE-PEG2000-NBD
ACMA00024696DSPE-PEG2000-NGR
ACMA00024697DSPE-PEG2000-NHS
ACMA00024698DSPE-PEG2000-OH
ACMA00024699DSPE-PEG2000-OPSS
ACMA00024700DSPE-PEG2000-OTC
ACMA00024701DSPE-PEG2000-PTP
ACMA00024702DSPE-PEG2000-RGD
ACMA00024703DSPE-PEG2000-SH
ACMA00024704DSPE-PEG2000-Silane
ACMA00024705DSPE-PEG2000-SP94
ACMA00024706DSPE-PEG2000-T7(HAIYPRH)
ACMA00024707DSPE-PEG2000-TAT

DSPE-PEG Terminal Derivatives

DSPE-PEG derivatives encompass various terminal modifications that further enhance the functionality of this polymer in biomedical applications. The terminal derivatives of DSPE-PEG include:

  • Amine-terminated DSPE-PEG

This derivative has an amine group at its terminal end, allowing for further conjugation with molecules containing carboxylic acid groups or other suitable reactive functional groups.

Amino-PEG-DSPE.Amino-PEG-DSPE. [1]

  • Carboxylic acid-terminated DSPE-PEG

In this derivative, the terminal end is a carboxylic acid group, which facilitates conjugation with molecules containing amino groups via peptide coupling or other bioconjugation chemistry.

  • Thiol-terminated DSPE-PEG

This derivative terminates with a thiol group, offering the potential for thiol-specific conjugation reactions, such as thiol-maleimide chemistry, forming stable covalent linkages with maleimide-functionalized molecules.

Hydroxyl-terminated DSPE-PEG

This derivative ends with a hydroxyl group, which can serve as an attachment point for various chemical modifications, such as esterification or etherification reactions.

  • Activated ester-terminated DSPE-PEG

The terminal end of this derivative contains an activated ester group, enabling facile conjugation with amine-containing molecules through nucleophilic substitution reactions.

  • Maleimide-terminated DSPE-PEG

This derivative features a maleimide group as its terminal end, suitable for selective and stable conjugation with thiols through Michael addition reactions.

Mal-PEG-SC.Mal-PEG-SC. [1]

DSPE-PEG for Vaccines Development

DSPE-PEG, due to its unique properties and functionalities, finds several applications in vaccine development and delivery. Here are the key applications of DSPE-PEG in vaccines:

  • Enhanced Stability

DSPE-PEG can be utilized to improve the stability of vaccine formulations. The PEG moiety provides steric hindrance and shields vaccine antigens or adjuvants from aggregation, enzymatic degradation, and physical or chemical instability, thereby extending the shelf-life of the vaccines.

  • Prolonged Circulation Half-Life

Incorporating DSPE-PEG into vaccine formulations can extend the circulation half-life of antigens or adjuvants in the bloodstream.

  • Targeted Delivery

DSPE-PEG can be engineered to enable targeted delivery of vaccine components to specific cells or tissues.

  • Adjuvant Delivery

DSPE-PEG can serve as a carrier for adjuvants, such as Toll-like receptor (TLR) agonists, enhancing their stability and enabling controlled release at the site of vaccination.

  • Modulation of Immune Response

By tuning the properties of DSPE-PEG-based vaccine carriers, it is possible to bias the immune response towards desired T-helper (Th) cell subsets, promoting either humoral (Th2-biased) or cellular (Th1-biased) immunity, as needed for specific vaccines.

References

  1. Dimitrios Bitounis, et al. International Scholarly Research Notices, 2012, 738432.
  2. Rongrong Wang, et al. International journal of nanomedicine, 2012, 7, 4185-4198.
  3. Che, Jing, et al. Current pharmaceutical design, 2015, 21(12), 1598-1605.

Our products and services are for research use only and cannot be used for any clinical purposes.